Literature DB >> 22020173

Presumed entecavir-induced ocular toxicity.

M K M Muqit, P E Stanga, F J Vilar, N Patton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22020173      PMCID： PMC3234485          DOI： 10.1038/eye.2011.259

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  5 in total

1.  High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy.

Authors:  Julio A Rodriguez-Padilla; Thomas R Hedges; Bryan Monson; Vivek Srinivasan; Maciej Wojtkowski; Elias Reichel; Jay S Duker; Joel S Schuman; James G Fujimoto
Journal:  Arch Ophthalmol       Date:  2007-06

Review 2.  Oculotoxicities of systemically administered drugs.

Authors:  P B Koneru; E J Lien; R T Koda
Journal:  J Ocul Pharmacol       Date:  1986

3.  Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.

Authors:  Ting-Tsung Chang; Yun-Fan Liaw; Shun-Sheng Wu; Eugene Schiff; Kwang-Hyub Han; Ching-Lung Lai; Rifaat Safadi; Samuel S Lee; Waldemar Halota; Zachary Goodman; Yun-Chan Chi; Hui Zhang; Robert Hindes; Uchenna Iloeje; Suzanne Beebe; Bruce Kreter
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

4.  Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.

Authors:  Michael F Marmor; Ulrich Kellner; Timothy Y Y Lai; Jonathan S Lyons; William F Mieler
Journal:  Ophthalmology       Date:  2011-02       Impact factor: 12.079

5.  A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.

Authors:  Ting-Tsung Chang; Robert G Gish; Robert de Man; Adrian Gadano; José Sollano; You-Chen Chao; Anna S Lok; Kwang-Hyub Han; Zachary Goodman; Jin Zhu; Anne Cross; Deborah DeHertogh; Richard Wilber; Richard Colonno; David Apelian
Journal:  N Engl J Med       Date:  2006-03-09       Impact factor: 91.245
  5 in total
  1 in total

1.  Reversible retinal toxicity in early oral Entecavir therapy for hepatitis-B infection.

Authors:  Suman Pilli; Peck Lin Lip
Journal:  Eye (Lond)       Date:  2018-06-22       Impact factor: 3.775
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.